rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-6-22
|
pubmed:abstractText |
To assess the antimicrobial elution characteristics, toxicity, and antimicrobial activity of amikacin-impregnated ferric-hyaluronate implants (AI-FeHAI) for amikacin delivery to the tarsocrural joint of horses.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1532-950X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
498-505
|
pubmed:dateRevised |
2011-4-25
|
pubmed:meshHeading |
pubmed-meshheading:19538672-Absorbable Implants,
pubmed-meshheading:19538672-Amikacin,
pubmed-meshheading:19538672-Animals,
pubmed-meshheading:19538672-Drug Delivery Systems,
pubmed-meshheading:19538672-Horses,
pubmed-meshheading:19538672-Hyaluronic Acid,
pubmed-meshheading:19538672-Injections, Intra-Articular,
pubmed-meshheading:19538672-Iron,
pubmed-meshheading:19538672-Tarsus, Animal
|
pubmed:year |
2009
|
pubmed:articleTitle |
In vitro and in vivo evaluation of ferric-hyaluronate implants for delivery of amikacin sulfate to the tarsocrural joint of horses.
|
pubmed:affiliation |
Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. ncribb@uoguelph.ca
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|